Methods and Products for Evaluating an Immune Response to a Therapeutic Protein

Details for Australian Patent Application No. 2012202823 (hide)

Owner Elan Pharmaceuticals, Inc. Biogen Idec MA Inc

Inventors Subramanyam, Meena; Amaravadi, Lakshmi; Wakshull, Eric; Lynn, Frances; Panzara, Michael; Barbour, Robin McDaid; Taylor, Julie Elizabeth

Agent Cullens

Pub. Number AU-A-2012202823

Parent 2006231511

Filing date 15 May 2012

Wipo publication date 7 June 2012

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

31 May 2012 Complete Application Filed

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202823

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202824-A gaming system and a method of gaming

2012202822-Inhibitors of Serine Proteases, Particularly HCV NS3-NS4A Protease